SCHEMBL17282440

SCHEMBL17282440

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4nc5cc6oc7ccccc7c6cc5s4)cc3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 9/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ NFKB1 P19838 4/20 0.45
▸ NFKB2 Q00653 4/20 0.45
▸ RELA Q04206 4/20 0.45
▸ LMNA P02545 2/20 0.45
▸ MAPT P10636 11/20 0.44
▸ GAA P10253 7/20 0.44
▸ ALDH1A1 P00352 6/20 0.44
▸ HPGD P15428 5/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ GLA P06280 4/20 0.44
▸ PKM P14618 2/20 0.44
▸ APP P05067 4/20 0.41
▸ POLB P06746 4/20 0.40
▸ CTDSP1 Q9GZU7 1/20 0.40
▸ RAB9A P51151 8/20 0.40
▸ NPC1 O15118 7/20 0.40
▸ GFER P55789 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24545437 0.96 KDM4E (0.42) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL15773491 0.89 KDM4E (0.42) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL24550398 0.89 KDM4E (0.46) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL15773494 0.89 KDM4E (0.40) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL24553434 0.89 KDM4E (0.40) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL24553404 0.88 KDM4E (0.41) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL24553086 0.88 KDM4E (0.38) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL24552090 0.88 KDM4E (0.43) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL24550582 0.88 KDM4E (0.39) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL24551757 0.88 KDM4E (0.39) KDM4ESMN1; SMN2NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2926385-B1 ELECTRONIC DEVICE MERCK PATENT GMBH (DE) 2020-08-05 — — EP disclosed
US-20150336959-A1 Electronic Device MERCK PATENT GMBH (DE) 2015-11-26 — — US disclosed
US-20150336959-A1 Electronic Device MERCK PATENT GMBH (DE) 2015-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336959-A1 Electronic Device ETFB, ETFA, XPOT KDM4E 3240/4885SMN1; SMN2 2933/4885NFKB1 3753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback